Polina Stepensky

7.2k total citations
134 papers, 2.5k citations indexed

About

Polina Stepensky is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Polina Stepensky has authored 134 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Immunology, 52 papers in Hematology and 36 papers in Oncology. Recurrent topics in Polina Stepensky's work include Hematopoietic Stem Cell Transplantation (37 papers), Immunodeficiency and Autoimmune Disorders (36 papers) and Immune Cell Function and Interaction (26 papers). Polina Stepensky is often cited by papers focused on Hematopoietic Stem Cell Transplantation (37 papers), Immunodeficiency and Autoimmune Disorders (36 papers) and Immune Cell Function and Interaction (26 papers). Polina Stepensky collaborates with scholars based in Israel, Germany and United States. Polina Stepensky's co-authors include Orly Elpeleg, Michael Weintraub, Avraham Shaag, Klaus Warnatz, Shoshana Revel‐Vilk, Adeeb NaserEddin, Irina Zaidman, Igor Resnick, Arndt Borkhardt and Reuven Or and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Polina Stepensky

128 papers receiving 2.5k citations

Peers

Polina Stepensky
V. Koneti Rao United States
Anne‐Sophie Korganow France
Corinne Miceli‐Richard France
John L. Wagner United States
Danielle Canioni France
James Verbsky United States
Tessa Kerre Belgium
Go Yamamoto Japan
Ryoji Ito Japan
Seah H. Lim United States
V. Koneti Rao United States
Polina Stepensky
Citations per year, relative to Polina Stepensky Polina Stepensky (= 1×) peers V. Koneti Rao

Countries citing papers authored by Polina Stepensky

Since Specialization
Citations

This map shows the geographic impact of Polina Stepensky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Polina Stepensky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Polina Stepensky more than expected).

Fields of papers citing papers by Polina Stepensky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Polina Stepensky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Polina Stepensky. The network helps show where Polina Stepensky may publish in the future.

Co-authorship network of co-authors of Polina Stepensky

This figure shows the co-authorship network connecting the top 25 collaborators of Polina Stepensky. A scholar is included among the top collaborators of Polina Stepensky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Polina Stepensky. Polina Stepensky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Auer, Franziska, Julie Vogt, Andrea Hänel, et al.. (2025). Trajectories from single-cells to PAX5-driven leukemia reveal PAX5-MYC interplay in vivo. Leukemia. 39(7). 1607–1626. 1 indexed citations
2.
Zaidman, Irina, Ehud Even‐Or, Diana Averbuch, et al.. (2023). Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases. Frontiers in Pediatrics. 11. 1194891–1194891. 5 indexed citations
3.
Zimran, Eran, et al.. (2023). Long-Term Results with Thiotepa-Containing Conditioning Regimens for Autologous Stem Cell Transplantation. Transplantation and Cellular Therapy. 29(8). 505.e1–505.e8. 1 indexed citations
4.
Keller, Baerbel, Shlomit Kfir‐Erenfeld, Frederike A. Hartl, et al.. (2023). Combined Immunodeficiency Caused by a Novel Nonsense Mutation in LCK. Journal of Clinical Immunology. 44(1). 4–4. 4 indexed citations
5.
Khare, Drirh, Reuven Or, Amnon Buxboim, et al.. (2023). Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Modulate Apoptosis, TNF Alpha and Interferon Gamma Response Gene mRNA Expression in T Lymphocytes. International Journal of Molecular Sciences. 24(18). 13689–13689. 4 indexed citations
6.
Vainstein, Vladimir, Batia Avni, Sigal Grisariu, et al.. (2023). Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg?. Cancers. 15(13). 3471–3471. 8 indexed citations
7.
Kfir‐Erenfeld, Shlomit, Batia Avni, Sigal Grisariu, et al.. (2023). Safety and Efficacy of a Locally Produced Novel Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) (HBI0101) for the Treatment of Relapsed and Refractory Multiple Myeloma. Blood. 142(Supplement 1). 4852–4852. 1 indexed citations
8.
Beyar‐Katz, Ofrat, Chava Perry, Efrat Luttwak, et al.. (2023). Response rates of extra‐nodal diffuse large B cell lymphoma to anti‐CD19‐CAR T cells: A real word retrospective multicenter study. European Journal Of Haematology. 111(1). 63–71. 4 indexed citations
9.
Carpenter, Paul A., Hyoung Jin Kang, Keon Hee Yoo, et al.. (2022). Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study. Transplantation and Cellular Therapy. 28(11). 771.e1–771.e10. 18 indexed citations
10.
Kfir‐Erenfeld, Shlomit, Sigal Grisariu, Batia Avni, et al.. (2022). Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis. Clinical Cancer Research. 28(23). 5156–5166. 21 indexed citations
11.
12.
Hajaj, Emma, Sharon Merims, Jonathan Cohen, et al.. (2021). Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions. Cancer Immunology Research. 9(6). 637–650. 14 indexed citations
13.
Pasvolsky, Oren, Liat Shargian, Uri Rozovski, et al.. (2021). Eltrombopag for enhancement of platelet engraftment in patients undergoing allogeneic cord blood transplantation. Leukemia & lymphoma. 62(11). 2747–2754. 5 indexed citations
14.
Shadur, Bella, Shlomit Kfir‐Erenfeld, Adeeb NaserEddin, et al.. (2020). A human case of GIMAP6 deficiency: a novel primary immune deficiency. European Journal of Human Genetics. 29(4). 657–662. 7 indexed citations
15.
Hinden, Liad, et al.. (2019). Lymphocyte counts may predict a good response to mesenchymal stromal cells therapy in graft versus host disease patients. PLoS ONE. 14(6). e0217572–e0217572. 10 indexed citations
16.
Even‐Or, Ehud, Adeeb NaserEddin, Bella Shadur, et al.. (2019). Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia. Pediatric Blood & Cancer. 67(1). e28010–e28010. 31 indexed citations
17.
Shadur, Bella, Irina Zaidman, Adeeb NaserEddin, et al.. (2018). Successful hematopoietic stem cell transplantation for osteopetrosis using reduced intensity conditioning. Pediatric Blood & Cancer. 65(6). e27010–e27010. 25 indexed citations
18.
Radomir, Lihi, Sivan Cohen, Matthias P. Kramer, et al.. (2017). T Cells Regulate Peripheral Naive Mature B Cell Survival by Cell–Cell Contact Mediated through SLAMF6 and SAP. The Journal of Immunology. 199(8). 2745–2757. 19 indexed citations
19.
Keller, Baerbel, Irina Zaidman, O. Sascha Yousefi, et al.. (2016). Early onset combined immunodeficiency and autoimmunity in patients with loss-of-function mutation in LAT. The Journal of Experimental Medicine. 213(7). 1185–1199. 44 indexed citations
20.
Stepensky, Polina, Anne Rensing‐Ehl, Shoshana Revel‐Vilk, et al.. (2014). Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency. Blood. 125(5). 753–761. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. Koneti Rao Breakdown of academic impact, for papers by Anne‐Sophie Korganow Breakdown of academic impact, for papers by Corinne Miceli‐Richard Breakdown of academic impact, for papers by John L. Wagner Breakdown of academic impact, for papers by Danielle Canioni Breakdown of academic impact, for papers by James Verbsky Breakdown of academic impact, for papers by Tessa Kerre Breakdown of academic impact, for papers by Go Yamamoto Breakdown of academic impact, for papers by Ryoji Ito Breakdown of academic impact, for papers by Seah H. Lim
Rankless by CCL
2026